Literature DB >> 2418431

Growth responses of normal, benign hyperplastic, and malignant human prostatic epithelial cells in vitro to cholera toxin, pituitary extract, and hydrocortisone.

D M Peehl, T A Stamey.   

Abstract

Normal, benign hyperplastic (BPH), and malignant prostatic epithelial cells from adult humans can be serially passaged in medium PFMR-4 supplemented with 20% whole serum, cholera toxin, and epidermal growth factor (EGF). Improved growth of these cells has been achieved by optimizing the concentrations of the components of the basal medium. In the new modified medium, PFMR-4A, the only supplements required are 5% dialyzed serum, cholera toxin, EGF, pituitary extract, and hydrocortisone. Comparative studies of the growth responses of prostatic cells derived from normal central zone, normal peripheral zone, BPH nodules, and adenocarcinomas did not reveal any qualitative differences; all respond positively to the addition of cholera toxin, pituitary extract, and hydrocortisone to the culture medium. Cells of one cancer strain, however, were much less density-dependent for growth than were the other strains of normal, BPH, or malignant cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2418431     DOI: 10.1002/pros.2990080107

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  13 in total

1.  Characterization of a fetal urogenital sinus mesenchymal cell line U4F: secretion of a negative growth regulatory activity.

Authors:  D R Rowley
Journal:  In Vitro Cell Dev Biol       Date:  1992-01

2.  Serum-free growth of adult human prostatic epithelial cells.

Authors:  D M Peehl; T A Stamey
Journal:  In Vitro Cell Dev Biol       Date:  1986-02

3.  Clonal growth characteristics of adult human prostatic epithelial cells.

Authors:  D M Peehl; S T Wong; T A Stamey
Journal:  In Vitro Cell Dev Biol       Date:  1988-06

Review 4.  Growth factors as mediators of androgen action during the development of the male urogenital tract.

Authors:  G R Cunha; B Foster; A Thomson; Y Sugimura; N Tanji; M Tsuji; N Terada; P W Finch; A A Donjacour
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

Review 5.  Prospects for vaccination in prostate cancer.

Authors:  M J Perry; D Hroulda; A G Dalgleish
Journal:  Drugs Aging       Date:  2000-05       Impact factor: 3.923

6.  Progenitor cells are responsible for formation primary epithelial cultures in the prostate epithelial model.

Authors:  Tomasz Drewa; Jan Styczynski
Journal:  Int Urol Nephrol       Date:  2007-02-22       Impact factor: 2.370

7.  Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5-alpha reductase inhibitor treated human benign prostate hyperplasia patients.

Authors:  Renjie Jin; Connor Forbes; Nicole L Miller; Douglas Strand; Thomas Case; Justin M Cates; Hye-Young H Kim; Phillip Wages; Ned A Porter; Krystin M Mantione; Sarah Burke; James L Mohler; Robert J Matusik
Journal:  Prostate       Date:  2022-07-12       Impact factor: 4.012

Review 8.  Prostate cancer progression. Implications of histopathology.

Authors:  J L Ware
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

Review 9.  Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer.

Authors:  J L Ware
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

10.  Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1.

Authors:  S W Hayward; R Dahiya; G R Cunha; J Bartek; N Deshpande; P Narayan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-01       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.